References
- Scioli MG, Bielli A, Gentile P, et al. Combined treatment with platelet-rich plasma and insulin favours chondrogenic and osteogenic differentiation of human adipose-derived stem cells in three-dimensional collagen scaffolds. J Tissue Eng Regen Med. 2017;11(8):2398–2410.
- Cervelli V, Lucarini L, Spallone D, et al. Use of platelet-rich plasma and hyaluronic acid in the loss of substance with bone exposure. Adv Ski Wound Care. 2011;24(4):176–181.
- Gentile P, Bottini DJ, Spallone D, et al. Application of platelet-rich plasma in maxillofacial surgery: clinical evaluation. J Craniofacial Surg. 2010;2(3):900–904.
- Gentile P, Cole JP, Cole MA, et al. Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and cytokine concentrations obtained by different collection systems. Int J Mol Sci. 2017;18:408.
- Harrison P. Subcommittee on platelet physiology. the use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16:1895–1900.
- Metcalf KB, Mandelbaum BR, McIlwraith CW. Application of platelet-rich plasma to disorders of the knee joint. Cartilage 2013;4:295–312.
- Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014;7:189–197.
- Gobbi A, Karnatzikos G, Mahajan V, et al. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012;4:162–172.
- Oh JH, Kim W, Roh YH, et al. Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations. Am J Sports Med. 2015;43:3062–3070.
- Schuklenk U, Ashcroft R. International research ethics. Bioethics. 2000;14(2):158–172.
- Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349.
- Sheth U, Simunovic N, Klein G, et al. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Jt Surg. 2012;94(4):298–307.
- De Angelis B, Mflm D, Orlandi F, et al. Wound healing: in vitro and in vivo evaluation of a bio-functionalized scaffold based on hyaluronic acid and platelet-rich plasma in chronic ulcers. J Clin Med. 2019;18:8.
- Mazzucco L, Balbo V, Cattana E, et al., Not every PRP gel is born equal. evaluation of growth factor availability for tissues through four prp-gel preparations: fibrinet, regenPRP-kit, plateltex and one manual procedure. Vox Sang. 97(2): 110–118. 2009. .
- Hamberg M, Svensson J, Samuelsson B. Thromboxanes—new group of biologically-active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA. 1975;72(8):2994–2998.
- Gentile P, Scioli MG, Bielli A, et al. Platelet-rich plasma and micrografts enriched with autologous human Follicle Mesenchymal stem cells improve hair re-growth in Androgenetic Alopecia. biomolecular pathway analysis and clinical evaluation. Biomedicines. 2019;7(2):27.
- Gentile P. Autologous cellular method using micrografts of human Adipose Tissue derived Follicle Stem Cells in Androgenic Alopecia. Int J Mol Sci. 2019;13:20.
- Anitua E, Sánchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42(2):162–170.
- Manusukiatti W, Maibach HI. Hyaluronic acid and skin: wound healing and aging. Int J Dermatol. 1996;35(8):539–544.
- Halim AS, Khoo TL, Saad AZ. Wound bed preparation from a clinical perspective. Indian J Plast Surg. 2012;45(2):193–202.
- Mehrabani D, Manafi N. Role of cultured skin fibroblasts in aesthetic and plastic surgery. World J Plast Surg. 2013;2(1):2–5.
- Kakudo N, Minakata T, Mitsui T, et al. Proliferation promoting effect of platelet-rich plasma on human adipose derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 2008;122(5):1352–1360.
- Ramos-Torrecillas J, García-Martínez O, De Luna-Bertos E, et al. Ectiveness of platelet-rich plasma and hyaluronic acid for the treatment and care of pressure ulcers. Biol Res Nurs. 2015;17(2):152–158.
- Margolis DJ, Cohen JH. Management of chronic venous leg ulcers: a literature-guided approach. Clin Dermatol. 1994;12(1):19–26.
- Costagliola M, Agrosi M. Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs silver sulfadiazine alone. Curr Med Res Opin. 2005;21(8):1235–1240.
- Cervelli V, Bocchini I, Di Pasquali C, et al. P.R.L. platelet rich lipotransfert: our experience and current state of art in the combined use of fat and PRP. Biomed Res Int. 2013;2013:434191.
- Cervelli V, Gentile P, De Angelis B, et al. Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in post-traumatic lower extremity ulcers. Stem Cell Res. 2011;6(2):103–111.
- Gentile P, Scioli MG, Bielli A, et al. Comparing different nanofat procedures on scars: role of the stromal vascular fraction and its clinical implications. Reg Med. 2017;12(8):939–995.
- Gentile P, Calabrese C, De Angelis B, et al. Impact of the different preparation methods to obtain human adipose-derived stromal vascular fraction cells (AD-SVFs) and human adipose-derived mesenchymal stem cells (AD-MSCs): enzymatic digestion versus mechanical centrifugation. Int J Mol Sci. 2019;20(21):5471.
- Gentile P, Kothari A, Casella D, et al. Fat graft enhanced with adipose-Derived stem cells in aesthetic breast augmentation: clinical, histological, and instrumental evaluation. Aesth Surg J. 2020;40(9):962–977.
- Gentile P, Sterodimas A, Pizzicannella J, et al. Systematic review: allogenic use of stromal vascular fraction (SVF) and decellularized extracellular matrices (ECM) as advanced therapy medicinal products (ATMP) in tissue regeneration. Int J Mol Sci. 2020;21(14):1–14.
- Gentile P, Sterodimas A, Pizzicannella J, et al. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), drugs, and vaccines in inhibiting COVID-19 disease. Aging Dis. 2020;11:1191–1201.
- Gentile P, Sterodimas A. Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a potential therapy in combating (COVID-19)-disease. Aging Dis. 2020;11:465–469.
- Gentile P, Sterodimas A. Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia. Exp Opin Biol Ther. 2020;20:711–716.
- Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endo. 2006;101:37–44.
- Ding ZY, Tan Y, Peng Q, et al. Novel applications of platelet concentrates in tissue regeneration (Review). Exp Ther Med. 2021;21(3):226.
- Gentile P, Garcovich S. Systematic Review: Adipose-derived mesenchymal stem cells, platelet-rich plasma and biomaterials as new regenerative strategies in Chronic Skin Wounds and soft tissue defects. Int J Mol Sci. 2021;22(4):1538.
- Chan GKL, Guo MS, Dai DK, et al. An optimized extract, named self-growth colony, from platelet-rich plasma shows robust skin rejuvenation and anti-ageing properties: a novel technology in development of cosmetics. Skin Pharmacol Physiol. 2021;1–12.
- Chamata ES, Bartlett EL, Weir D, et al. Platelet-rich plasma: evolving role in plastic surgery. Plast Reconstr Surg. 2021;147(1):219–230.